Carregant...
Tumor Necrosis Factor α-Converting Enzyme Inhibition Reverses Hepatic Steatosis and Improves Insulin Sensitivity Markers and Surgical Outcome in Mice
BACKGROUND: Hepatic steatosis is an established risk factor for complications following major hepatic resection. Pharmacological options to reverse steatosis prior to surgery, however, are lacking. We hypothesized that treatment with the pharmacologic tumor necrosis factor-α converting enzyme (TACE)...
Guardat en:
Autors principals: | , , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Public Library of Science
2011
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3181348/ https://ncbi.nlm.nih.gov/pubmed/21980496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0025587 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|